Αποτελέσματα Αναζήτησης
14 Σεπ 2021 · Magnesium sulphate (MgSO 4) is recommended for prevention and treatment of pre-eclampsia/eclampsia. However, MgSO 4 remains underused, particularly in low- and middle-income countries (LMICs).
Magnesium sulphate administration is indicated to treat eclamptic seizures and prevent seizures in women with severe pre-eclampsia. Pharmacological strategies for control of blood pressure are described in detail.
1 Ιουν 2024 · Magnesium sulfate is a mandatory medication for patients with eclampsia and, therefore, all centers responsible for caring for pregnant women must have this medication, regardless of their level of care.
PK/PD models have used concentration-time profile data of individuals to describe magnesium disposition in pregnant women who received common magnesium sulfate dosing regimens for either preeclampsia or fetal neuroprotection.
Magnesium sulfate is one of the most commonly used medications in obstetrics, most notably for the prevention of eclamptic seizures and fetal neuroprotection of the extremely preterm neonate. Pharmacokinetic and pharmacodynamic studies have demonstrated a variety of IV and IM regimens are effective …
Shifting the use of magnesium sulfate by expansion to facilities attended by health workers with minimal training could optimize pregnancy outcomes for affected women.
24 Νοε 2016 · To characterise the current clinical practice patterns regarding the use of magnesium sulphate (MgSO 4) for eclampsia prevention and treatment in a multi-country network of health facilities and compare with international recommendations.
